Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MAGI2 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547901
Description
In direct ELISAs, less than 1% cross-reactivity with recombinant ARIP-2 is observed. Reconstitute in sterile PBS to a final concentration of 0.2 mg/mL.
Seems to act as scaffold molecule at synaptic junctions by assembling neurotransmitter receptors and cell adhesion proteins. May play a role in regulating activin-mediated signaling in neuronal cells. Enhances the ability of PTEN to suppress AKT1 activation. Plays a role in nerve growth factor (NGF)-induced recruitment of RAPGEF2 to late endosomes and neurite outgrowth. Florindo C.S., Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases. The MGC Project Team, Genome Res. 14:2121-2127(2004). Devroe E., J. Biol. Chem. 279:24444-24451(2004).
Specifications
MAGI2 | |
Polyclonal | |
Unconjugated | |
MAGI2 | |
activin receptor interacting protein 1; activin receptor-interacting protein 1; Acvri1; ACVRINP1; Acvrip1; AIP1; AIP-1; ARIP1; Atrophin-1-interacting protein 1; atrophin-1-interacting protein A; KIAA0705; MAGI2; MAGI-2; membrane associated guanylate kinase, WW and PDZ domain containing 2; membrane-associated guanylate kinase inverted 2; Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2; mKIAA0705; Sscam; S-SCAM; Synaptic-scaffolding molecule | |
Goat | |
Antigen affinity chromatography | |
RUO | |
50791, 9863 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
Q86UL8, Q9WVQ1 | |
MAGI2 | |
E. coli-derived recombinant human MAGI2 Ser2-Arg130. | |
100 μg | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction